EFFECTS OF IRON AND DESFERRIOXAMINE ON THE GROWTH OF PLASMODIUM-FALCIPARUM INVITRO

EFFECTS OF IRON AND DESFERRIOXAMINE ON THE GROWTH OF PLASMODIUM-FALCIPARUM INVITRO

Detalhes bibliográficos
Principais autores:	Peto, T, Thompson, J
Formato:	Journal article
Publicado em:	1987

Registros relacionados

A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.
por: Peto, T, et al.
Publicado em: (1986)

Survival and desferrioxamine in thalassaemia major.
por: Modell, B, et al.
Publicado em: (1982)

Preliminary Phytochemical Analysis and Invitro Antiplasmodial Activity of Terminalia mantaly Against Plasmodium falciparum
por: Bello Muhammad Usman, et al.
Publicado em: (2022-12-01)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Ricchi Paolo, et al.
Publicado em: (2011-02-01)

Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro.
por: Whitehead, S, et al.
Publicado em: (1990)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Capra Marcello, et al.
Publicado em: (2011-02-01)

Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron.
por: Roxana Y P Alta, et al.
Publicado em: (2017-01-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
por: Ebrahim miri moghaddam, et al.
Publicado em: (2011-04-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
por: Mohammad Ali Mashhadi, et al.
Publicado em: (2011-06-01)

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone
por: Paul T. Telfer, et al.
Publicado em: (2009-12-01)

Effects of iron concentration and DFB (Desferrioxamine-B) on transcriptional profiles of an ecologically relevant marine bacterium
por: Gary R. LeCleir, et al.
Publicado em: (2023-01-01)

Desferrioxamine-Related Pseudo-Vitelliform Dystrophy and the Effect of Anti-Vascular Endothelial Growth Factor
por: Michael E. Grinton, et al.
Publicado em: (2021-01-01)

The desferrioxamine-prochlorperazine coma – clue to the role of dopamine-iron recycling in the synthesis of hydrogen peroxide in the brain.
por: John eSmythies, et al.
Publicado em: (2014-08-01)

Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
por: Umit Nusret Basaran, et al.
Publicado em: (2013-01-01)

Dual Role of Desferrioxamine in Erwinia amylovora Pathogenicity
por: Alia Dellagi, et al.
Publicado em: (1998-08-01)

Effects of desferrioxamine on serum erythropoietin and ventilatory sensitivity to hypoxia in humans.
por: Ren, X, et al.
Publicado em: (2000)

Influence of host iron status on Plasmodium falciparum infection
por: Martha A. Clark, et al.
Publicado em: (2014-05-01)

Tales of the Unexpected: The Case of Zirconium(IV) Complexes with Desferrioxamine
por: Matteo Savastano, et al.
Publicado em: (2019-06-01)

Desferrioxamine-related ocular toxicity: A case report
por: Sumu Simon, et al.
Publicado em: (2012-01-01)

Effects of riboflavin and desferrioxamine B on Fe(II) oxidation by O2
por: Peng Zhang, et al.
Publicado em: (2022-03-01)

Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment
por: Dahlui, M., et al.
Publicado em: (2009)

Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
por: Simon A. M. Kaeppeli, et al.
Publicado em: (2019-05-01)

Growth of Plasmodium falciparum in response to a rotating magnetic field
por: Rebecca C. Gilson, et al.
Publicado em: (2018-05-01)

Assessment of the effect of combination therapy with Deferiprone & Desferrioxamine on cardiac complications in major Thalassemia
por: F. Rashidi ghader, M.D, et al.
Publicado em: (2007-01-01)

Invivo and invitro evaluation of antitumor effects of iron oxide and folate core shell-iron oxide nanoparticles
por: N. N. H. Shosha, et al.
Publicado em: (2022-01-01)

Housing conditions and <it>Plasmodium falciparum </it>infection: protective effect of iron-sheet roofed houses
por: Séraphin Simboro, et al.
Publicado em: (2006-02-01)

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging
por: Alessia Pepe, et al.
Publicado em: (2011-01-01)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
por: Borgna-Pignatti Caterina, et al.
Publicado em: (2011-02-01)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
por: Maggio Aurelio, et al.
Publicado em: (2011-02-01)

Desferrioxamine-Laden Nanofibrous Scaffolds with Efficient Angiogenesis for Accelerating Diabetic Wound Healing
por: Zhao Y, et al.
Publicado em: (2024-10-01)

Malária grave por Plasmodium falciparum Severe Plasmodium falciparum malaria
por: Andréia Patrícia Gomes, et al.
Publicado em: (2011-09-01)

Desferrioxamine Supports Metabolic Function in Primary Human Macrophages Infected With Mycobacterium tuberculosis
por: James Joseph Phelan, et al.
Publicado em: (2020-05-01)

Fetal hemoglobin does not inhibit Plasmodium falciparum growth
por: Natasha M. Archer, et al.
Publicado em: (2019-07-01)

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria.
por: Chiodini, P, et al.
Publicado em: (1995)

Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children
por: Bundi, CK, et al.
Publicado em: (2020)

Invitro rearing of parasitoids
por: Jumaev Rasul
Publicado em: (2023-01-01)

Rahnella aquatilis JZ-GX1 alleviates iron deficiency chlorosis in Cinnamomum camphora by secreting desferrioxamine and reshaping the soil fungal community
por: Wei-Liang Kong, et al.
Publicado em: (2022-09-01)

Evolução dos gametos do Plasmodium falciparum Evolution of the gametes of Plasmodium falciparum
por: Henrique de Beaurepaire Aragão
Publicado em: (1930-09-01)

Characterization of the substrate binding site of an iron detoxifying membrane transporter from Plasmodium falciparum
por: Pragya Sharma, et al.
Publicado em: (2021-06-01)

Desferrioxamine elevates pulmonary vascular resistance in humans: potential for involvement of HIF-1.
por: Balanos, G, et al.
Publicado em: (2002)